AB 1880: Valley Fever reporting.
- Session Year: 2017-2018
- House: Assembly
- Latest Version Date: 2018-03-01
Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever.
This bill would clarify that cases of both communicable and noncommunicable diseases are to be timely reported by a health care provider to a local health officer, and by a local health officer to the department. The bill would require a health care provider with a duty to report a case or suspected case of a communicable or noncommunicable disease to complete a one-time mandatory training course on that duty, as specified.This bill would require the department to collect data on coccidioidomycosis cases on or before April 1 each year, as specified. The bill would require the department, if it collects data on coccidioidomycosis cases and alters that data, removes discrepant data from its internal data set, to timely report sufficient information about its removal of discrepant data to a local health officer how and why it altered the data reported by in order that the local health officer. officer may remove discrepant data from the countys data set. The bill would also require the department, if it publishes provisional data on coccidioidomycosis cases, to publish an explanation of data changes likely to occur and of discrepancies between data reported by a local health officer and data reported by the department. The bill would require the department to publish the date range of a data set and the date on which the data set was updated if the department publishes data on coccidioidomycosis cases.
Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever.
This bill would clarify that cases of both communicable and noncommunicable diseases are to be timely reported by a health care provider to a local health officer, and by a local health officer to the department. The bill would require a health care provider with a duty to report a case or suspected case of a communicable or noncommunicable disease to complete a one-time mandatory training course on that duty, as specified.
This bill would require the department, if it collects data on coccidioidomycosis cases and alters that data, to timely report to a local health officer how and why it altered the data reported by the local health officer. The bill would also require the department, if it publishes provisional data on coccidioidomycosis cases, to publish an explanation of data changes likely to occur and of discrepancies between data reported by a local health officer and data reported by the department.
(a)If(1)On or before April 1 each year, the department shall collect data on coccidioidomycosis cases from the following:
(A)The California Reportable Disease Information Exchange (CalREDIE).
(B)Another electronic data system used by a local health department, or via a Form 8280 submitted by a local health officer, or both.
(2)A coccidioidomycosis case diagnosed during the preceding year, but reported after April 1, shall be included in the next years data collection and attributed to the year of diagnosis in future data reporting.
(b)If the department collects data on coccidioidomycosis cases from a local health officer and alters that data removes discrepant data from its internal data set for any reason, including, but not limited to, to delete duplicate cases reported by multiple counties, the department shall timely report to a in a timely manner sufficient information about its removal of discrepant data to the local health officer how and why it altered the data originally reported by that local health officer. so that the local health officer may remove discrepant data from the countys data set.
(b)(c)If the department publishes provisional data on coccidioidomycosis cases, the department shall include in its publication an explanation for likely data changes between initial and final publication, and an explanation for discrepancies between data reported by a local health officer and data reported by the department.
(d)If the department publishes data on coccidioidomycosis cases, the department shall include in its publication the date range of the data set published and the date on which the published data set was updated.
(a)The department shall establish a list of reportable diseases and conditions. For each reportable disease and condition, the department shall specify the timeliness requirements related to the reporting of each disease and condition, and the mechanisms required for, and the content to be included in, reports made pursuant to this section. The
(1)The list of reportable diseases and conditions may include both communicable and noncommunicable diseases. The list may include those diseases that are either known to be, or suspected of being, transmitted by milk or milk-based products. The
(2)The list may be modified at any time by the department, after consultation with the California Conference of Local Health Officers. Modification of the list shall be exempt from the administrative regulation and rulemaking requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, and shall be implemented without being adopted as a regulation, except that the revised list shall be filed with the Secretary of State and printed in the California Code of Regulations as required pursuant to subdivision (e). Those
(3)Those communicable and noncommunicable diseases listed as reportable shall be properly reported as required to the department by the local health officer.
(4)Those communicable and noncommunicable diseases listed as reportable shall be properly reported as required to the local health officer by a health care provider. A health care provider required to report a case or suspected case of a communicable or noncommunicable disease shall complete a one-time mandatory training course on the duty to report cases to the local health officer by January 1, 2020, or within two years of the start of his or her duty to report.
(b)The department shall establish a list of communicable diseases and conditions for which clinical laboratories shall submit a culture or a specimen to the local public health laboratory. The list shall set forth the conditions under which the culture and specimen shall also be submitted to the State Public Health Laboratory. The list may be modified at any time by the department, in consultation with appropriate local public health stakeholders, including, but not limited to, local health officers and public health laboratory directors. Both establishment and modification of the list shall be exempt from the administrative regulation and rulemaking requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, and shall be implemented without being adopted as a regulation, except that the initial list and any modifications shall be filed with the Secretary of State and printed in the California Code of Regulations as required pursuant to subdivision (e).
(c)The department may from time to time adopt and enforce regulations requiring strict or modified isolation, or quarantine, for any of the contagious, infectious, or communicable diseases, if in the opinion of the department the action is necessary for the protection of the public health.
(d)The local health officer may require strict or modified isolation, or quarantine, for any a case of contagious, infectious, or communicable disease, when this action is necessary for the protection of the public health.
(e)The lists established pursuant to subdivisions (a) and (b) and any subsequent modifications shall be published in Title 17 of the California Code of Regulations.
(f)Notwithstanding any other provision of law, no a civil or criminal penalty, fine, sanction, or finding, or denial, suspension, or revocation of licensure for any a person or facility may shall not be imposed based upon a failure to provide the notification of a reportable disease or condition or to provide the submission of a culture or specimen that is required under this section, unless the name of the disease or condition that is required to be reported, or for which a culture or specimen is required to be submitted, was printed in the California Code of Regulations and the department notified the person or facility of the disease or condition at least six months prior to before the date of the claimed failure to report or submit.
(g)Commencing July 1, 2009, or within one year of the establishment of a state electronic laboratory reporting system, whichever is later, a report generated pursuant to this section, or Section 121022, by a laboratory shall be submitted electronically in a manner specified by the department. The department shall allow laboratories that receive incomplete patient information to report the name of the provider who submitted the request to the local health officer.
(h)The department may, through its Internet Web site and via electronic mail, advise out-of-state laboratories that are known to the department to test specimens from California residents of the new reporting requirements.
SEC. 2.Section 120132 is added to the Health and Safety Code, to read:120132.(a)If the department collects data on coccidioidomycosis cases from a local health officer and alters that data for any reason, including, but not limited to, to delete duplicate cases reported by multiple counties, the department shall timely report to a local health officer how and why it altered the data originally reported by that local health officer.
(b)If the department publishes provisional data on coccidioidomycosis cases, the department shall include in its publication an explanation for likely data changes between initial and final publication, and an explanation for discrepancies between data reported by a local health officer and data reported by the department.
|
Date
|
Status
|
|---|---|
| Mar 20, 2018 | In committee: Set, first hearing. Hearing canceled at the request of author. |
| Mar 5, 2018 | Re-referred to Com. on HEALTH. |
| Mar 1, 2018 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Jan 29, 2018 | Referred to Com. on HEALTH. |
| Jan 18, 2018 | From printer. May be heard in committee February 17. |
| Jan 17, 2018 | Read first time. To print. |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: March 20, 2018
ASSEMBLY COMMITTEE ON HEALTH
Jim Wood, Chair
ABPCA Bill Id:AB 1880
Author:Fong – As Amended Ver:March 1, 2018
SUBJECT: Valley Fever reporting.
SUMMARY: Requires the Department of Public Health (DPH) to collect data on coccidioidomycosis cases, also known as Valley Fever, on or before April 1 each year. Specifically, this bill:
- Requires DPH to collect data on cases of Valley Fever from the following:
- California Reportable Disease Information Exchange (CalREDIE); and,
- Another electronic data system used by a local health department, or via Form 8280 submitted by a local health officer (LHO), or both.
- Requires, if DPH collects data on Valley Fever cases from a LHO and removes discrepant data from DPH’s internal data set for any reason, DPH to report in a timely manner, sufficient information about the removal of discrepant data to the LHO.
- Requires, if DPH publishes provisional data on Valley Fever cases, to include an explanation for data changes between initial and final publication and an explanation for discrepancies between data reported by LHOs and DPH.
- Requires, if DPH publishes data on Valley Fever cases, for the publication to include the date range of a data set and the date on which the data was updated.
EXISTING LAW:
- Requires DPH to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirement for the reporting of each disease and condition.
- Requires every health care provider, knowing of or in attendance on a case or suspected case of any of diseases or conditions as specified, to report to the LHO for the jurisdiction where the patient resides.
- Requires an administrator of each health facility, clinic, or other setting where more than one health care provider may know of a case, a suspected case or an outbreak of disease within the facility to establish and be responsible for administrative procedures to assure that reports are made to the local officer health officer.
- Requires LHOs to report cases of identified diseases to DPH.
FISCAL EFFECT: This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the authors, Valley Fever has affected every region in California, but has been particularly endemic to the Central Valley. Statewide there were over 5,300 cases reported in 2016— a jump of 71% over 2015. Over 40% of these cases were from Kern County alone. Valley Fever is known as the “silent epidemic” and the number of cases continues to increase. However, the number of reported cases can often vary between state and local public health officials. The authors argue that we need a solution that will enable state and local health officials to improve information sharing so that we have the best available data to combat this “silent epidemic.” According to the authors, this bill provides consistency and transparency in the reporting of Valley Fever cases with the goal of ensuring that state and local health officials are receiving the most up-to-date and accurate data. The authors conclude that this bill will continue to build the partnership between state and local officials in order to educate, raise awareness for, and eradicate Valley Fever.
- BACKGROUND.
- Valley Fever. Valley Fever is an infectious disease caused by a fungus, Coccidioides, which is found in arid soil and desert-like regions of California, the southwestern region of the U.S., parts of Mexico, Central America, and South America. Individuals and domestic animals can become infected with Valley Fever through breathing in the microscopic Coccidioides fungus spores. Anyone who lives, works, or visits areas with the contaminated soil is at risk for Valley Fever. It is important to note that individuals and/or animals infected with Valley Fever are not contagious. The majority of counties in California have reported cases of Valley Fever, but a large portion of Valley Fever cases are found in the California Central Valley. According to DPH, approximately 60% of infected individuals will not present any symptoms. However, for many individuals infected with Valley Fever they will present with flu-like symptoms which last from a few weeks to a few months. Approximately 5-10% of individuals infected will develop severe Valley Fever and may suffer life-long complications. In very rare cases Valley Fever can be fatal.
There is no vaccine to prevent infection or cure for those who have been infected, but current research is working towards this goal. State funding for the Valley Fever Vaccine Project began with a budget augmentation request by then-Assemblymember Ashburn for $700,000 in 1997-98. In 2009, the Budget Act included an ongoing appropriation of $1 million to continue research activities earmarked toward the development of a vaccine. Funding was subsequently discontinued in 2010. In 2015, SB 115 (Fuller) was introduced which would have appropriated $1 million from the General Fund to DPH for Valley Fever vaccine research. SB 115 was held in the Assembly Appropriations Committee. Numerous similar allocation requests between 2002 and 2014 were held in the Assembly Appropriations Committee. Currently, Assemblymembers Salas and Fong have budget proposals regarding appropriations for Valley Fever vaccine research and a Valley Fever public awareness campaign.
- Reporting Process. Valley Fever can mimic many common diseases, such as influenza or pneumonia. Therefore, patient cases are reported as suspected until laboratory results can confirm a patient has Valley Fever. Health care providers report suspected and confirmed cases to LHDs. LHDs are then mandated to report all cases of Valley Fever to DPH. Valley Fever cases are continuously reported by LHDs to DPH throughout the year, mainly through the statewide electronic disease reporting system, CalREDIE. However, cases remain provisional until the LHD completes their investigation and finalizes the report case. Early in the year, DPH sets a deadline for all reported disease cases, including Valley Fever, to be finalized and closed by LHDs. According to DPH, after this deadline DPH processes and analyzes the final data and posts a summary of final data approximately 3 months later. In 2017, DPH began posting monthly reports on provisional Valley Fever cases. Both DPH and LHDs can review cases in CalREDIE and assess whether case information meets the Valley Fever case definition. According to DPH, when changes are made at the state level to data reported by an LHD, the LHDs can see changes through CalREDIE and therefore can verify the case.
- Valley Fever Workgroup (Workgroup). In response to the increase of Valley Fever cases, DPH recently convened a Valley Fever Workgroup. The purpose of the Workgroup is to improve understanding, standardize surveillance, and hold opportunities for communication between DPH and LHDs from endemic areas of Valley Fever. The Workgroup first met in October of 2017, and continues to meet monthly. It has four specific goals:
- To better understand how each local health jurisdiction is currently conducting surveillance of Valley Fever;
- Develop a plan for systematic and standardized approach to Valley Fever surveillance in California; including the possibility of a revised case definition for disease monitoring that will facilitate more rapid reporting and case confirmation;
- Discuss ways to increase public awareness of Valley Fever with the public and also medical providers; and,
- Determine the need for new Valley Fever educational materials and additional tools for possible Valley Fever outbreaks.
- To better understand how each local health jurisdiction is currently conducting surveillance of Valley Fever;
- SUPPORT. The Valley Fever Americas Foundation (VFAF) states this bill will improve case reporting between state and local officials. VFAF also notes that due to the alarming increase in cases, it is crucial that we have the best available data. VFAF concludes this bill will provide consistency and transparency in the reporting of Valley Fever cases with the goal of ensuring the state and local health officials are receiving the most up-to-date and accurate data.
- RELATED LEGISLATION.
- AB 1787 (Salas and Fong) requires DPH to establish an annual deadline beginning on March 1, 2019, for LHOs to report all cases of Valley Fever to DPH. AB 1787 is pending in the Assembly Health Committee.
- AB 1788 (Salas and Fong) requires DPH, for the purpose of reporting confirmed cases of Valley Fever, to use laboratory criteria with or without clinical criteria. AB 1788 is pending in the Assembly Health Committee.
- AB 1789 (Salas and Fong) requires the Occupational Safety and Health Standards Board to adopt occupational safety and health standard for state public work projects to prevent Valley Fever. AB 1789 passed 6-0 in the Assembly Labor and Employment Committee and is pending in the Assembly Appropriations Committee.
- AB 1790 (Salas and Fong) requires mandatory training for physicians and surgeons on preventing, diagnosing, and treating Valley Fever. AB 1790 is pending in the Assembly Business and Professions Committee.
- AB 1881 (Fong and Salas) requires DPH to develop standardized methodology for Valley Fever laboratory tests. AB 1881 is pending in the Assembly Health Committee.
- PREVIOUS LEGISLATION. AB 1279 (Salas) of 2017 would have required DPH to develop and implement a public outreach program to educate individuals about Valley Fever. AB 1279 was vetoed by the Governor, who stated:
“I am returning Assembly Bill 1279 without my signature.
This bill requires the Department of Public Health to develop outreach programs to educate the public about Valley Fever.
The department already provides fact sheets, brochures, posters, and other educational materials to raise awareness of this disease. Expanding this program would necessitate additional resources which should be considered along with other funding requests as part of the budget process.”
- POLICY COMMENT. This bill is substantially similar to AB 1787 (Salas and Fong) regarding reporting deadlines for Valley Fever cases.
REGISTERED SUPPORT / OPPOSITION:
Support
Bakersfield City Council
Valley Fever Americas Foundation
Wonderful Company LLC
Opposition
None on file.
Analysis Prepared by: Monica Montano / HEALTH / (916) 319-2097
Bill Author
Bill Co-Author(s):